The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin
Open accessAbstract
Most patients (80%) with ovarian cancer (OvCa) present with metastatic disease. Attachment of OvCa cells to peritoneum and omentum represents the first rate-limiting step for metastatic spread. Therefore, identifying factors regulating cell attachment in the abdominal cavity is critical to the development of therapeutic agents. We show here that MMP-2 expression was upregulated in OvCa cells upon attachment to their microenvironment. Downregulation of MMP-2 mRNA or pharmacological inhibition of MMP-2 proteolytic function, in both human OvCa primary cells and cell lines, reduced attachment of OvCa cells to a 3D organotypic model of metastatic OvCa, full human omentum or peritoneum, and in vivo to mouse peritoneum and omentum. Absence of MMP-2 in the host did not alter OvCa adhesion, as determined utilizing mice harboring homozygous null mutations in either the Mmp2 or Mmp9 genes. Conversely, adhesion induced upregulation of MMP-2 mRNA in OvCa cells. MMP-2 inhibition in OvCa cells through pharmacological or antibody treatment prior to i.p. dissemination in nude mice significantly decreased tumor growth and metastasis and extended survival. MMP-2 enhanced peritoneal adhesion of OvCa cells through cleavage of ECM proteins fibronectin (FN) and vitronectin (Vn) into small fragments and increased binding of OvCa cells to these FN and Vn fragments and their receptors, alpha5beta1 and alphaVbeta3 integrin. These findings indicate that MMP-2 expressed by metastatic OvCa cells functionally regulates their attachment to peritoneal surfaces.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
RAG-1-deficient mice have no mature B and T lymphocytes
Mombaerts, P., Iacomini, J., Johnson, R. S., Herrup, K., Tonegawa, S., & Papaioannou, V. E. (1992) · Cell · doi:10.1016/0092-8674(92)90030-g · Cited by 2,931
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
Self-citationCannistra, S. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041842 · Cited by 2,129
Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., & Werb, Z. (1998) · Cell · doi:10.1016/s0092-8674(00)81169-1 · Cited by 1,750
MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis
Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000) · Cell · doi:10.1016/s0092-8674(00)00139-2 · Cited by 1,306
Self-citationInduction of Cell Migration by Matrix Metalloprotease-2 Cleavage of Laminin-5
Giannelli, G., Falk-Marzillier, J., Schiraldi, O., Stetler-Stevenson, W. G., & Quaranta, V. (1997) · Science · doi:10.1126/science.277.5323.225 · Cited by 1,221
Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice
Bergers, G., Javaherian, K., Lo, K.-M., Folkman, J., & Hanahan, D. (1999) · Science · doi:10.1126/science.284.5415.808 · Cited by 988
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., & Hanahan, D. (1999) · Genes & Development · doi:10.1101/gad.13.11.1382 · Cited by 946
Self-citationReduced angiogenesis and tumor progression in gelatinase A-deficient mice.
Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., & Itohara, S. (1998) · PubMed · Cited by 875
Tumor targeting with a selective gelatinase inhibitor
Koivunen, E., Arap, W., Valtanen, H., Rainisalo, A., Medina, O. P., Heikkilä, P., Kantor, C., Gahmberg, C. G., Salo, T., Konttinen, Y. T., et al. (1999) · Nature Biotechnology · doi:10.1038/11703 · Cited by 567
Liotta, L. A., Abe, S., Robey, P. G., & Martin, G. R. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.5.2268 · Cited by 449
Bramhall, S. R., Rosemurgy, A., Brown, P. D., Bowry, C., Buckels, J. A. C., & for the Marimastat Pancreatic Cancer Study Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.15.3447 · Cited by 438
Sequence-specific transcriptional activation is essential for growth suppression by p53.
Pietenpol, J. A., Tokino, T., Thiagalingam, S., el-Deiry, W. S., Kinzler, K. W., & Vogelstein, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.1998 · Cited by 406
Davies, B. P., Brown, P. D., East, N., Crimmin, M., & Balkwill, F. R. (1993) · PubMed · Cited by 382
Huang, S. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.15.1134 · Cited by 349
Schmalfeldt, B., Prechtel, D., Härting, K., Späthe, K., Rutke, S., Konik, E., Fridman, R., Berger, U., Schmitt, M., Kuhn, W. C., et al. (2001) · PubMed · Cited by 334
Self-citationBian, J., & Sun, Y. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6330 · Cited by 276
Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial
Bramhall, S. R., Hallissey, M. T., Whiting, J., Scholefield, J., Tierney, G., Stuart, R. C., Hawkins, R. E., McCulloch, P., Maughan, T., Brown, P. D., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600310 · Cited by 265
Sawada, K., Radjabi, A. R., Shinomiya, N., Kistner, E., Kenny, H., Becker, A. R., Turkyilmaz, M. A., Salgia, R., Yamada, S. D., Vande Woude, G. F., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1147 · Cited by 258
Self-citationKenny, H. A., Krausz, T., Yamada, S. D., & Lengyel, E. (2007) · International Journal of Cancer · doi:10.1002/ijc.22874 · Cited by 243
Chantrain, C. F., Shimada, H., Jodele, S., Groshen, S., Ye, W., Shalinsky, D. R., Werb, Z., Coussens, L. M., & DeClerck, Y. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0160 · Cited by 218
Self-citationAbnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines.
Yaginuma, Y., & Westphal, H. (1992) · PubMed · Cited by 214
Phase III Study of Matrix Metalloproteinase Inhibitor Prinomastat in Non–Small-Cell Lung Cancer
Bissett, D., O’Byrne, K. J., von Pawel, J., Gatzemeier, U., Price, A., Nicolson, M., Mercier, R., Mazabel, E., Penning, C., Zhang, M. H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.170 · Cited by 209
Tumor cell α3β1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis
Wang, H., Fu, W., Im, J. H., Zhou, Z., Santoro, S. A., Iyer, V., DiPersio, C. M., Yu, Q.-C., Quaranta, V., Al-Mehdi, A., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200309112 · Cited by 199
Expression and activity of MMPS and their regulators in ovarian cancer
Naylor, M. S., Stamp, G. W., Davies, B. D., & Balkwill, F. R. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580110 · Cited by 168
Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2
Hu, B., Guo, P., Fang, Q., Tao, H.-Q., Wang, D., Nagane, M., Su Huang, H.-J., Gunji, Y., Nishikawa, R., Alitalo, K., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533394100 · Cited by 164
Tam, E. M., Wu, Y., Butler, G. S., Stack, M. S., & Overall, C. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206874200 · Cited by 144
Antimetastatic Activity of a Novel Mechanism-Based Gelatinase Inhibitor
Krüger, A., Arlt, M., Gerg, M., Kopitz, C., Bernardo, M. M., Chang, M., Mobashery, S., & Fridman, R. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3570 · Cited by 127
Expression and Function of β1 and αvβ3 Integrins in Ovarian Cancer
Cannistra, S. A., Ottensmeier, C. H. H., Niloff, J. M., Orta, B., & DiCarlo, J. (1995) · Gynecologic Oncology · doi:10.1006/gyno.1995.1214 · Cited by 126
Hagiwara, K., McMenamin, M. G., Miura, K., & Harris, C. C. (1999) · PubMed · Cited by 122
Expression and function of β1 and αvβ3 integrins in ovarian cancer
(1996) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(96)84550-4 · Cited by 120
Regulation of p53 Nuclear Export through Sequential Changes in Conformation and Ubiquitination
Nie, L., Sasaki, M. M., & Maki, C. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610515200 · Cited by 114
Moser, T. L., Pizzo, S. V., Bafetti, L. M., Fishman, D. A., & Stack, M. S. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960904)67:5<695::aid-ijc18>3.0.co;2-4 · Cited by 113
Yan, C., Wang, H., & Boyd, D. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112069200 · Cited by 93
Giavazzi, R., Garofalo, A., Ferri, C., Lucchini, V., Bone, E. A., Chiari, S., Brown, P. D. N., Nicoletti, M. I., & Taraboletti, G. (1998) · PubMed · Cited by 86
Ried, S., Jäger, C., Jeffers, M., Woude, G. F. V., Graeff, H., Schmitt, M., & Lengyel, E. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16377 · Cited by 86
Self-citationLakka, S. S., Gondi, C. S., Yanamandra, N., Dinh, D. H., Olivero, W. C., Gujrati, M., & Rao, J. S. (2003) · PubMed · Cited by 82
Lengyel, E. R., Gum, R. J., Juárez, J., Clayman, G. L., Seiki, M., Sato, H., & Boyd, D. D. (1995) · PubMed · Cited by 78
Self-citationInhibition of Matrix Metalloproteinase 9 Activation by a Specific Monoclonal Antibody
RAMOS‐DeSIMONE, N., Moll, U. M., Quigley, J. P., & French, D. L. (1993) · Hybridoma · doi:10.1089/hyb.1993.12.349 · Cited by 70
MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts
Boyd, R. S., & Balkwill, F. R. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690357 · Cited by 58
Watson, S. A., Morris, T. M., Collins, H. M., Bawden, L. J., Hawkins, K., & Bone, E. A. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690645 · Cited by 56
Carreiras, F., Rigot, V., Cruet, S., Andr�, F., Gauduchon, P., & Marvaldi, J. L. (1999) · International Journal of Cancer · Cited by 53
Introduction of wild-type p53 in a human ovarian cancer cell line not expressing endogenous p53
Vikhanskaya, F., Erba, E., D’Incalci, M., & Broggini, M. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.6.1012 · Cited by 49
Hapke, S., Gawaz, M., Dehne, K., Köhler, J., Marshall, J. F., Graeff, H., Schmitt, M., Reuning, U., & Lengyel, E. R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.6.2118-2132.2001 · Cited by 49
Self-citationIn vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer.
Modesitt, S. C., Ramírez, P. J., Zu, Z., et al. (2001) · PubMed · Cited by 46
Sampling the omentum in ovarian neoplasia: when one block is enough
Doig, T., & Monaghan, H. (2006) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00273.x · Cited by 34
Westerlund, A., Hujanen, E., Puistola, U., & Turpeenniemi-Hujanen, T. (1997) · Gynecologic Oncology · doi:10.1006/gyno.1997.4808 · Cited by 30
Cited by
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
Friedl, P., & Alexander, S. (2011) · Cell · doi:10.1016/j.cell.2011.11.016 · Cited by 1,940
Ovarian Cancer Development and Metastasis
Lengyel, E. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100105 · Cited by 1,672
Self-citationRethinking ovarian cancer: recommendations for improving outcomes
Vaughan, S., Coward, J. I., Bast, R. C., Berchuck, A., Berek, J. S., Brenton, J. D., Coukos, G., Crum, C. C., Drapkin, R., Etemadmoghadam, D., et al. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3144 · Cited by 1,464
Self-citationLoessner, D., Stok, K. S., Lutolf, M. P., Hutmacher, D. W., Clements, J. A., & Rizzi, S. C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.064 · Cited by 602
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
Felder, M., Kapur, A., Gonzalez-Bosquet, J., Horibata, S., Heintz, J., Albrecht, R., Fass, L., Kaur, J., Hu, K., Shojaei, H., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-129 · Cited by 524
Metadata
- Authors
- Kenny, H. A., Kaur, S., Coussens, L. M., & Lengyel, E.
- Venue
- Journal of Clinical Investigation
- Published
- 2008-04-01
- Volume
- 118
- Issue
- 4
- Pages
- 1367-1379
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1997559135
- Cited by
- 370
- References
- 50
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.